Abrilumab Found Effective for Moderate-to-Severe Ulcerative Colitis Relative to Placebo

A second alpha integrin molecule is tested in an industry-supported phase II trial.

Source link

Related posts

Routine Genomic Risk Screening Coming Soon to an Office Near You?


Fecal Microbiota Transplant Cuts Bloodstream Infection in C. diff


2018 Public Policy Year in Review: what did ACG do for you?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World